- With Mayo Clinic diabetes educators
Nancy Klobassa Davidson, R.N., and Peggy Moreland, R.N.
read biographyclose windowBiography of
Nancy Klobassa Davidson, R.N., and Peggy Moreland, R.N.
Nancy Klobassa Davidson and Peggy Moreland
Nancy Klobassa Davidson, R.N., B.S.N, C.D.E
Nancy Klobassa Davidson is a registered nurse who has worked in diabetes education for 17 years. She is a certified diabetes educator (C.D.E.) and is currently in graduate school working on a Master of Science in nursing (M.S.N.) and health care education.Nancy works with adults who have type 1, type 2 and other forms of diabetes. Nancy is coordinator of the Diabetes Unit's intensive insulin therapy program within the Division of Endocrinology, Diabetes, Metabolism, & Nutrition at Mayo Clinic in Rochester, Minn. Nancy has worked extensively with insulin pump therapy and continuous interstitial glucose sensing.
Peggy Moreland, R.N., M.S.N.
Peggy Moreland is a certified diabetes educator (C.D.E.) in the Division of Endocrinology, Diabetes, Metabolism, & Nutrition at Mayo Clinic in Rochester, Minn.Peggy graduated with a Master of Science in Nursing and Health Care Education from the University of Phoenix and is a member of the American Association of Diabetes Educators and the American Diabetes Association. A certified diabetes educator (C.D.E.), Peggy enjoys working with patients to set and achieve diabetes self-management goals.
Latest entries
- Preventing diabetic retinopathy
Feb. 4, 2012
- Teens with diabetes: Transitioning to adult care
Jan. 20, 2012
- Diabetes: Setting goals
Dec. 30, 2011
- Diabetes: Don't forget to laugh
Dec. 21, 2011
- Generational influence and controlling impulses
Nov. 17, 2011
About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Living with diabetes blog
-
Jan. 10, 2012
Psychological insulin resistance stems from fear
By Nancy Klobassa Davidson, R.N., and Peggy Moreland, R.N.
Insulin dramatically increases the life expectancy of persons with type 1 diabetes. Those with type 2 diabetes have also benefited from modern insulins. However, about a third of those with type 2 diabetes are unwilling to take insulin. Here's a few of the reasons that we hear for "psychological insulin resistance":
- Guilt — Beginning insulin therapy may make individuals feel that they have failed at managing their diabetes.
- Needle phobia.
- Insulin injections would restrict their lifestyle.
- Insulin causes weight gain.
- Fear their diabetes is now serious.
- Fear of getting low blood sugars.
- In western society, insulin is viewed as a last resort.
- Association of insulin therapy and complications in close relatives.
Due to the progressive loss of beta cell function in type 2 diabetes, most of those with type 2 will likely require insulin at some point.
Complications of uncontrolled type 2 diabetes are well documented. Type 2 diabetes is falsely perceived as mild.
Beginning insulin therapy indicates to some people that their diabetes is now more serious. People with type 2 diabetes often feel fine and may wonder why they should start insulin. The greatest barrier to starting insulin is the fear of gaining weight, but with lifestyle counseling the weight gain overall is modest.
Healthcare providers are also reluctant to initiate insulin therapy even when a person has a high A1C. The provider's attitude has a significant impact on the patient's attitudes and beliefs regarding insulin. Often, insulin therapy is used as a threat to force people to make lifestyle changes. Or, clinicians can use it as a scare tactic — a threat if the person with diabetes does not comply with prescribed oral agents. Labeling insulin therapy negatively makes people with diabetes feel like they've failed.
Recently, I had a patient tell me she didn't ever want to go on insulin. She wasn't starting on it, but when she repeated the statement I asked her why. She said she didn't want the hassle of having to give herself injections. I mentioned that when a person with type 2 diabetes needs to start insulin, they are often started on a once-daily long acting insulin injection. She was surprised, relieved and said that wouldn't be bad at all.
What are your thoughts?
Peggy
24 comments posted